All In Biotech

Free tool

FAERS Monitor: Intelence

The FDA Adverse Event Reporting System collects reports from patients, clinicians and manufacturers. Counts are unverified reports, not rates: they rise with how widely a drug is used, how long it has been sold and media attention, a report can name several drugs, and a report does not show the drug caused the event.

Last checked: Nov 20, 2026FDA FAERS (openFDA) last updated: Oct 28, 2026Methods & limitations

Reports naming NDA 022187 or its brand name (Intelence, Etravirine). Reports on generic versions are filed under their own applications.

Reports

4,438

Serious

3,903

88% of reports

Hospitalization

1,291

Death reported

475

Any cause; not necessarily from the drug

Most reported reactions

MedDRA preferred terms.

  • pain286
  • drug interaction282
  • drug resistance266
  • anxiety247
  • emotional distress243
  • virologic failure237
  • anhedonia219
  • death208
  • treatment failure203
  • chronic kidney disease192
  • lipodystrophy acquired175
  • foetal exposure during pregnancy166
  • renal failure165
  • anaemia163
  • drug ineffective160

Reports by year received

View as table
YearReports
200759
2008153
2009255
2010257
2011196
2012278
2013265
2014257
2015375
2016343
2017267
2018250
2019317
2020369
2021222
2022231
2023158
202493
202545
202648

Disproportionality screen

Proportional reporting ratio (PRR): how much more often each reaction appears in this drug's reports than in the other 21,049,721 FAERS reports. Flagged when PRR is at least 2, chi-squared at least 4 and there are 3 or more reports (Evans criteria). A screening statistic only.

ReactionReportsPRR95% CI lowerChi-squared
lipodystrophy acquiredSignal175425.7365.767,653
virologic failureSignal237218.4192.448,844
drug resistanceSignal26649.644.112,498
anhedoniaSignal21939.835.08,190
chronic kidney diseaseSignal19212.010.51,928
treatment failureSignal20311.610.21,966
foetal exposure during pregnancySignal1669.78.41,288
emotional distressSignal2439.58.41,854
drug interactionSignal2828.47.51,852
renal failureSignal1655.95.1669
anxietySignal2474.13.6587
anaemiaSignal1634.13.5375
painSignal2862.22.0193
death2081.11.04
drug ineffective1600.60.553

A high PRR for a reaction that is also the condition being treated (for example "disease progression" for a cancer drug) is expected and is not a safety signal.

For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.